FindTrial
Sign In

cyclosporine ophthalmic emulsion

DRUG2 trials

Sponsors

University of Alabama at Birmingham, Vanderbilt-Ingram Cancer Center

Conditions

Chronic Myeloproliferative DisordersContact Lens Wearers With Dry Eye SyndromeGraft Versus Host DiseaseLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms

Phase 3

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
CompletedNCT00755040
Vanderbilt-Ingram Cancer CenterChronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia +4
Start: 2008-10-31End: 2016-05-31Updated: 2017-03-07

Unknown Phase

Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers
CompletedNCT00335114
University of Alabama at BirminghamContact Lens Wearers With Dry Eye Syndrome
Start: 2005-11-30End: 2006-04-30Target: 40Updated: 2023-05-09